Immunosuppressive monocytes promote infection in patients with alcohol-associated hepatitis

Background: Broad immune cell dysfunction known as immune paralysis is a hallmark of severe alcohol-associated hepatitis (AH). This process may drive susceptibility to infection and contribute to high short-term mortality in these patients. However, the mechanisms of immune paralysis are incompletely understood. The aim of this study was to elucidate the role of myeloid cells in immune dysfunction in severe AH to identify potential biomarkers of infection risk and therapeutic targets. Methods and Results: We analyzed the peripheral immune compartment of AH patients, heavy drinkers, and healthy controls and discovered that AH patients at risk for infection had an expanded peripheral monocyte population that was CXCR5 + CCR4 + (C-X-C chemokine receptor type 5, C-C chemokine receptor type 4) and had lower activity of pro-inflammatory pathways (eg, Tumor Necrosis Factor alpha, TNF-α, and Interleukin-1 beta, IL-1β) compared with controls. The frequency of circulating CXCR5 + CCR4 + monocytes in AH patients negatively correlated with 12-month transplant-free survival. Ex vivo CXCR5 + AH monocytes had reduced phagocytic activity, and they suppressed T-cell proliferation compared with CXCR5 − and healthy control monocytes. CXCR5 + AH monocytes expressed PD-L1 (Programmed Death Ligand 1), which is a costimulatory molecule known to inhibit T-cell activation, and TMEM176B (Tolerance-Related and Induced, TORID-1), which is an intracellular cation channel that regulates calcium flux. Inhibition of TORID-1 promoted human monocyte phagocytosis and IL-1β release. Conclusions: CXCR5 + CCR4 + monocytes arise in patients with severe AH and have impaired phagocytosis, reduced pro-inflammatory cytokine production, and suppress T-cell proliferation. These cells may promote susceptibility to bacterial infection and predict outcomes in severe AH. These may represent novel therapeutic targets to alleviate immune dysfunction in severe AH.

Authors

Institutions

Publication Details

Journal
Hepatology Communications
Published
2026-11-20
DOI
https://doi.org/10.1097/hc9.0000000000001073
Primary Topic
Alcohol Consumption and Health Effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Immunosuppressive monocytes promote infection in patients with alcohol-associated hepatitis

Harmeet Malhi, Nidhi Jalan‐Sakrikar, Enis Kostallari, Brett M. McGettigan et al.
Hepatology Communications
Alcohol Consumption and Health Effects
article

Immunosuppressive monocytes promote infection in patients with alcohol-associated hepatitis

Harmeet Malhi, Nidhi Jalan‐Sakrikar, Enis Kostallari, Brett M. McGettigan, Vijay H. Shah, Tejasav S. Sehrawat, Sofía Jerez, Shawna A. Cooper, Dawood Al Dawood, Laura Rogers, AlcHepNet investigators and the TREAT investigators
article en

Abstract

Background: Broad immune cell dysfunction known as immune paralysis is a hallmark of severe alcohol-associated hepatitis (AH). This process may drive susceptibility to infection and contribute to high short-term mortality in these patients. However, the mechanisms of immune paralysis are incompletely understood. The aim of this study was to elucidate the role of myeloid cells in immune dysfunction in severe AH to identify potential biomarkers of infection risk and therapeutic targets. Methods and Results: We analyzed the peripheral immune compartment of AH patients, heavy drinkers, and healthy controls and discovered that AH patients at risk for infection had an expanded peripheral monocyte population that was CXCR5 + CCR4 + (C-X-C chemokine receptor type 5, C-C chemokine receptor type 4) and had lower activity of pro-inflammatory pathways (eg, Tumor Necrosis Factor alpha, TNF-α, and Interleukin-1 beta, IL-1β) compared with controls. The frequency of circulating CXCR5 + CCR4 + monocytes in AH patients negatively correlated with 12-month transplant-free survival. Ex vivo CXCR5 + AH monocytes had reduced phagocytic activity, and they suppressed T-cell proliferation compared with CXCR5 − and healthy control monocytes. CXCR5 + AH monocytes expressed PD-L1 (Programmed Death Ligand 1), which is a costimulatory molecule known to inhibit T-cell activation, and TMEM176B (Tolerance-Related and Induced, TORID-1), which is an intracellular cation channel that regulates calcium flux. Inhibition of TORID-1 promoted human monocyte phagocytosis and IL-1β release. Conclusions: CXCR5 + CCR4 + monocytes arise in patients with severe AH and have impaired phagocytosis, reduced pro-inflammatory cytokine production, and suppress T-cell proliferation. These cells may promote susceptibility to bacterial infection and predict outcomes in severe AH. These may represent novel therapeutic targets to alleviate immune dysfunction in severe AH.

Hepatology CommunicationsVol. 10(12)
Mayo Clinic (US), Yale University (US)
Alcohol Consumption and Health Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon